[1] 何权瀛. 哮喘-慢阻肺重叠综合征的诊断和治疗以及管理一事的由来和结局[J]. 中国呼吸与危重监护杂志,2021,20(1):1-3. DOI:10.7507/1671-6205.202012083.
[2] Baron AJ, Flokstra-de Blok BMJ, van Heijst E, et al. Prevalence of asthma characteristics in COPD patients in a Dutch Well-Established Asthma/COPD service for primary care[J]. Int J Chron Obstruct Pulmon Dis, 2020, 15: 1601-1611. DOI: 10.2147/COPD.S247819.
[3] 赵亚静,李江英. 多索茶碱与布地奈德对慢性阻塞性肺疾病急性加重期的疗效[J]. 吉林医学,2024,45(4):864-866. DOI:10.3969/j.issn.1004-0412.2024.04.031.
[4] 辛亚男,吕欣,梁芳,等. 乙酰半胱氨酸联合布地奈德雾化对AECOPD患者肺功能及气道炎症反应的影响[J]. 国际医药卫生导报,2023,29(24):3556-3561. DOI:10.3760/cma.j.issn.1007-1245.2023.24.007.
[5] Piskin E, Cetinkaya A, Unal MA,et al. A molecularly imprinted polymer-based detection platform confirmed through molecular modeling for the highly sensitive and selective analysis of ipratropium bromide[J]. J Pharm Biomed Anal, 2024, 248: 116283. DOI: 10.1016/j.jpba.2024.116283.
[6] 陈福将,吴超雄,何丽丹,等. 吸入用复方异丙托溴铵溶液雾化吸入治疗儿童哮喘急性发作的临床研究[J]. 中国临床药理学杂志,2023,39(11):1523-1527. DOI:10.13699/j.cnki.1001-6821.2023.11.001.
[7] Chen C, Wu L, Wang L, et al. Probiotics combined with budesonide and ipratropium bromide for chronic obstructive pulmonary disease: a retrospective analysis[J]. Medicine (Baltimore), 2024, 103(10):e37309. DOI: 10.1097/MD.0000000000037309.
[8] Lv C, Liao G, Wu L, et al. Effects of different intervention factors on vascular endothelial growth factor-induced human airway smooth muscle cell migration[J]. Can Respir J, 2022, 2022: 6879539. DOI: 10.1155/2022/6879539.
[9] 孙永昌. 哮喘-慢阻肺重叠综合征指南解读[J]. 中国呼吸与危重监护杂志,2014,13(4):325-329. DOI:10.7507/1671-6205.2014080.
[10] Nugmanova D, Feshchenko Y, Iashyna L, et al. Association between body mass index and patient-reported-outcome questionnaire scores (CAT™, ACT™, mMRC dyspnoea scale, IPAQ) in Ukraine, Kazakhstan and Azerbaijan: results of the CORE study[J]. BMC Pulm Med, 2021, 21(1):192. DOI: 10.1186/s12890-021-01542-2.
[11] 沈泽昊,霍美蓉,金方. 治疗哮喘慢性阻塞性肺疾病双功能药物的研究现状[J]. 中国临床药理学杂志,2022,38(11):1278-1282. DOI:10.13699/j.cnki.1001-6821.2022.11.029.
[12] Leung C, Sin DD. Asthma-COPD overlap: what are the important questions?[J]. Chest, 2022, 161(2):330-344. DOI: 10.1016/j.chest.2021.09.036.
[13] Wongsurakiat P, Rattanawongpaibul A, Limsukon A, et al. Expert panel consensus recommendations on the utilization of nebulized budesonide for managing asthma and COPD in both stable and exacerbation stages in Thailand[J]. J Asthma, 2024, 61(10): 1136-1151. DOI: 10.1080/02770903.2024.2334897.
[14] Hashemi ST, Alikiaii B, Mohkamkar N. The effect of ipratropium bromide with violet flower extract, ipratropium bromide with budesonide, and ipratropium bromide alone on the cuff-leak of the endotracheal tube in intubated ICU patients[J]. Adv Biomed Res, 2023, 12: 74. DOI: 10.4103/abr.abr_265_21.
[15] 王彩丽,陈玉,张少雯. 吸入用异丙托溴铵联合盐酸氨溴索对老年肺癌患者化疗后肺功能的影响[J]. 中国老年学杂志,2023,43(11):2613-2616. DOI:10.3969/j.issn.1005-9202. 2023.11.015.
[16] 赵珂,王少芳,张芳芳. 布地奈德福莫特罗、异丙托溴铵雾化吸入联合NIPPV治疗COPD合并Ⅱ型呼吸衰竭疗效观察[J]. 海南医学,2024,35(3):319-323. DOI:10.3969/j.issn.1003-6350.2024.03.004.
[17] Bansal A, Mostafa MM, Kooi C, et al. Interplay between nuclear factor-κB, p38 MAPK, and glucocorticoid receptor signaling synergistically induces functional TLR2 in lung epithelial cells[J]. J Biol Chem, 2022, 298(4): 101747. DOI: 10.1016/j.jbc.2022.101747.
[18] Baker JR, Mahdi M, Nicolau DV, et al. Early Th2 inflammation in the upper respiratory mucosa as a predictor of severe COVID-19 and modulation by early treatment with inhaled corticosteroids: a mechanistic analysis[J]. Lancet Respir Med, 2022, 10(6):545-556. DOI: 10.1016/S2213-2600(22)00002-9.
[19] 梅亚玲. 布地奈德联合异丙托溴铵对阻塞性肺气肿患者气血参数及肺功能的影响[J]. 实用医技杂志,2020,27(5):643-644. DOI:10.19522/j.cnki.1671-5098.2020.05.047.
[20] Davis BE, Cockcroft DW. Effect of daily dosing with tiotropium against methacholine induced bronchoconstriction in asthmatics[J]. Pulm Pharmacol Ther, 2022, 77: 102174. DOI: 10.1016/j.pupt.2022. 102174.
[21] Hollenhorst MI, Krasteva-Christ G. Nicotinic acetylcholine receptors in the respiratory tract[J]. Molecules, 2021, 26(20):6097. DOI: 10.3390/molecules26206097.
[22] 陈利娟,刘晓丹,陈敏,等. 布地奈德联合异丙托溴铵雾化治疗小儿支气管肺炎的疗效分析[J]. 国际医药卫生导报,2023,29(23):3443-3447. DOI:10.3760/cma.j.issn.1007- 1245.2023.23.027.
[23] 徐娇,黄聪聪,赵颖. 肺力咳联合盐酸异丙托溴铵吸入治疗支气管哮喘并肺炎的效果分析[J]. 现代诊断与治疗,2022,33(17):2551-2553,2556.
[24] Csoma B, Beringer F, Szűcs G, et al. Measurements of upper and lower airway nitric oxide in healthy adults[J]. J Breath Res, 2021, 15(4): 2567. DOI: 10.1088/1752-7163/ac2567.
[25] Suleiman S, Klassen S, Katz I, et al. Argon reduces the pulmonary vascular tone in rats and humans by GABA-receptor activation[J]. Sci Rep, 2019, 9(1): 1902. DOI: 10.1038/s41598-018-38267-y.
[26] Duan Q, Zhou Y, Yang D. Endoplasmic reticulum stress in airway hyperresponsiveness[J]. Biomed Pharmacother, 2022, 149: 112904. DOI: 10.1016/j.biopha.2022.112904.
[27] Zhong ZG, Dong CP, Guo XH, et al. Long noncoding RNA ANRIL up-regulates CCND1 via sponging miR-98-5p to promote TGF-β1-induced human airway smooth muscle cell proliferation, migration, and extracellular matrix deposition[J]. Kaohsiung J Med Sci, 2022, 38(7): 633-642. DOI: 10.1002/kjm2.12538.
[28] XuChen X, Weinstock J, Arroyo M, et al. Airway remodeling factors during early-life rhinovirus infection and the effect of premature birth[J]. Front Pediatr, 2021, 9: 610478. DOI: 10.3389/fped.2021.610478.
[29] Raby KL, Michaeloudes C, Tonkin J, et al. Mechanisms of airway epithelial injury and abnormal repair in asthma and COPD[J]. Front Immunol, 2023,14: 1201658. DOI: 10.3389/fimmu.2023.1201658.
[30] He H, Ji X, Cao L, et al. Medicine targeting epithelial-mesenchymal transition to treat airway remodeling and pulmonary fibrosis progression[J]. Can Respir J, 2023, 2023: 3291957. DOI: 10.1155/2023/3291957.
|